Advanced Glycation End Products: Association with the Pathogenesis of Diseases and the Current Therapeutic Advances

E-ISSN： 2212-3938|11|2|118-127

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.11, Iss.2, 2016-08, pp. : 118-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 973-978

Bentham Science Publishers

Access to resources Recommend Favorite

Prion Diseases: Current Understanding of Epidemiology and Pathogenesis, and Therapeutic Advances

By Caramelli Maria

CNS Drugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 15-28

Adis International

Access to resources Recommend Favorite

Advanced glycation end products and diabetic complications

By Stitt Alan W Jenkins Alicia J Cooper Mark E

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1205-1223

Informa Healthcare

Access to resources Recommend Favorite

The Road to Advanced Glycation End Products: A Mechanistic Perspective

Current Medicinal Chemistry, Vol. 14, Iss. 15, 2007-06 ,pp. : 1653-1671

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Advanced Glycation End Products in Diabetic Neuropathy

Current Pharmaceutical Design, Vol. 14, Iss. 10, 2008-04 ,pp. : 953-961

Bentham Science Publishers

Access to resources Recommend Favorite